• SENSEX
    NIFTY 50
Business

COVID-19 treatment: How Gilead's licensing agreement for remdesivir will progress

Updated : May 13, 2020 11:14 PM IST

This is the second voluntary license agreement that Gilead has signed.
The earlier instance was in 2014-2015 for Gilead’s antiviral drug Sofosbuvir for treatment of Hepatitis C
COVID-19 treatment: How Gilead's licensing agreement for remdesivir will progress

You May Also Like

Live TV
Advertisement